Stay up-to-date on our latest developments
OXURION to Participate in Upcoming Investor Meetings
Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a clinical stage portfolio in vascular retinal disorders, today announces its management will participate and meet with investors at the following upcoming virtual meetings:
Panel presentation (Goldeneye) scheduled on August 11 at 9:45 AM ET
Pre-Recorded CEO Presentation available starting on August 17 at 7:00 AM ET
Panel presentation (Vision Repair Beyond Traditional Anti-VEGF) scheduled on August 17 at 12:00 PM ET
For more information, please visit Oxurion’s events page.